REVASUR Trademark

Trademark Overview

On Wednesday, May 5, 2021, a trademark application was filed for REVASUR with the United States Patent and Trademark Office. The USPTO has given the REVASUR trademark a serial number of 90690946. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, August 14, 2024. This trademark is owned by Azurity Pharmaceuticals, Inc.. The REVASUR trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical formulations and compositions containing topiramate; pharmaceutical preparations for the preventative treatment of seizures or migraines; anticonvulsants
revasur

General Information

Serial Number90690946
Word MarkREVASUR
Filing DateWednesday, May 5, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, August 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements

Goods and Servicespharmaceutical formulations and compositions containing topiramate; pharmaceutical preparations for the preventative treatment of seizures or migraines; anticonvulsants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAzurity Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801
Party NameAzurity Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events

Event DateEvent Description
Friday, January 7, 2022ASSIGNED TO EXAMINER
Friday, August 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 15, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 25, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 25, 2022SOU EXTENSION 1 FILED
Thursday, August 25, 2022SOU EXTENSION 1 GRANTED
Saturday, August 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 15, 2023SOU EXTENSION 2 FILED
Wednesday, March 15, 2023SOU EXTENSION 2 GRANTED
Friday, March 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024SOU EXTENSION 4 FILED
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2023SOU EXTENSION 3 FILED
Wednesday, August 23, 2023SOU EXTENSION 3 GRANTED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024SOU EXTENSION 4 GRANTED
Friday, February 16, 2024SOU TEAS EXTENSION RECEIVED
Saturday, February 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU EXTENSION 5 GRANTED
Wednesday, August 14, 2024SOU EXTENSION 5 FILED

Related Keywords

revasur pharmaceutical treatment seizures migraines anticonvulsants preventative preparations formulations compositions containing